| Molecular mechanisms of metastasis in breast cancer—clinical applications M Mego, SA Mani, M Cristofanilli Nature reviews Clinical oncology 7 (12), 693-701, 2010 | 308 | 2010 |
| Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment M Giuliano, A Giordano, S Jackson, KR Hess, U De Giorgi, M Mego, ... Breast Cancer Research 13, 1-9, 2011 | 258 | 2011 |
| Epithelial–mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer A Giordano, H Gao, S Anfossi, E Cohen, M Mego, BN Lee, S Tin, ... Molecular cancer therapeutics 11 (11), 2526-2534, 2012 | 244 | 2012 |
| Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study M Mego, J Chovanec, I Vochyanova-Andrezalova, P Konkolovsky, ... Complementary therapies in medicine 23 (3), 356-362, 2015 | 211 | 2015 |
| Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy M Mego, SA Mani, BN Lee, C Li, KW Evans, EN Cohen, H Gao, ... International journal of cancer 130 (4), 808-816, 2012 | 183 | 2012 |
| Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors Z Cierna, M Mego, V Miskovska, K Machalekova, M Chovanec, ... Annals of oncology 27 (2), 300-305, 2016 | 150 | 2016 |
| Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination M Giuliano, A Giordano, S Jackson, U De Giorgi, M Mego, EN Cohen, ... Breast cancer research 16, 1-9, 2014 | 149 | 2014 |
| Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer Z Cierna, M Mego, P Janega, M Karaba, G Minarik, J Benca, ... BMC cancer 14, 1-8, 2014 | 137 | 2014 |
| Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells M Mego, U De Giorgi, S Dawood, X Wang, V Valero, E Andreopoulou, ... International journal of cancer 129 (2), 417-423, 2011 | 130 | 2011 |
| Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells EN Cohen, H Gao, S Anfossi, M Mego, NG Reddy, B Debeb, A Giordano, ... PloS one 10 (7), e0132710, 2015 | 122 | 2015 |
| Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+ CD24lo cancer stem … JM Reuben, BN Lee, H Gao, EN Cohen, M Mego, A Giordano, X Wang, ... European journal of cancer 47 (10), 1527-1536, 2011 | 122 | 2011 |
| Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy M Mego, V Holec, L Drgona, K Hainova, S Ciernikova, V Zajac Complementary therapies in medicine 21 (6), 712-723, 2013 | 117 | 2013 |
| Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer U De Giorgi, M Mego, E Scarpi, M Giuliano, A Giordano, JM Reuben, ... Clinical breast cancer 12 (4), 264-269, 2012 | 113 | 2012 |
| Circulating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer U De Giorgi, V Valero, E Rohren, M Mego, GV Doyle, MC Miller, NT Ueno, ... Annals of oncology 21 (1), 33-39, 2010 | 102 | 2010 |
| Circulating tumor cells (CTC) are associated with defects in adaptive immunity in patients with inflammatory breast cancer M Mego, H Gao, EN Cohen, S Anfossi, A Giordano, T Sanda, TM Fouad, ... Journal of Cancer 7 (9), 1095, 2016 | 95 | 2016 |
| Prognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation M Mego, H Gao, BN Lee, EN Cohen, S Tin, A Giordano, Q Wu, P Liu, ... Journal of Cancer 3, 369, 2012 | 85 | 2012 |
| Systemic immune-inflammation index in germ-cell tumours M Chovanec, Z Cierna, V Miskovska, K Machalekova, K Kalavska, ... British journal of cancer 118 (6), 831-838, 2018 | 84 | 2018 |
| 18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer U De Giorgi, M Mego, EM Rohren, P Liu, BC Handy, JM Reuben, ... Journal of Nuclear Medicine 51 (8), 1213-1218, 2010 | 83 | 2010 |
| CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer M Mego, D Cholujova, G Minarik, T Sedlackova, P Gronesova, M Karaba, ... Bmc Cancer 16, 1-9, 2016 | 80 | 2016 |
| Long-term cognitive dysfunction in cancer survivors Z Országhová, M Mego, M Chovanec Frontiers in molecular biosciences 8, 770413, 2021 | 77 | 2021 |
Francisco J. EstevaChief, Breast Medical Oncology, Northwell Health Cancer Institute at Lenox Hill Hospital在 northwell.edu 的电子邮件经过验证
Francisco J. EstevaChief, Breast Medical Oncology, Northwell Health Cancer Institute at Lenox Hill Hospital在 northwell.edu 的电子邮件经过验证